44 Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
44 Wealth Management's PFE Position: Q1 2026 in Review
44 Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 24,805 shares — an estimated $618K sold.
44 Wealth Management first reported a position in PFE in Q4 2020 and held it in 15 quarters. The position peaked at $3.88M in Q4 2022. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- 44 Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- 44 Wealth Management sold 24,805 Pfizer shares in Q1 2026, an estimated $618K.
- 44 Wealth Management first reported a position in Pfizer in Q4 2020 and held it in 15 quarters.
- 44 Wealth Management's Pfizer position peaked at $3.88M in Q4 2022.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.